EUVIMEDEUVIMED entdecken
Evaluationsstudie

Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center

Lisa Piasecki, Charlotte Genestet, Yvonne Benito, Jean-Philippe Rasigade, Gérard Lina, Oana Dumitrescu, Elisabeth Hodille

European Journal of Clinical Microbiology & Infectious Diseases · 2024

DOI: 10.1007/s10096-024-04825-8 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2024. Verfasst von Lisa Piasecki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire des Mycobactérie, Laboratoire de biologie médicale multi-site, Groupement Hospitalier Nord, Hospices civils de Lyon, Lyon, France. Hauptthemen laut MEDLINE: Nontuberculous Mycobacteria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Rapid, reliable identification of mycobacteria from positive cultures is essential for patient management, particularly for the differential diagnosis of Mycobacterium tuberculosis complex (MTBC) and nontuberculous mycobacteria (NTM) species. The aim of the present study was to evaluate a new "In-Vitro-Diagnostic"-certified PCR kit, FluoroType®-Mycobacteria VER 1.0 (Hain Lifescience GmbH) for NTM and MTBC identification from cultures. METHODS: Mycobacteria identification isolated from positive cultures during routine practice at the Lyon university hospital mycobacteria laboratory obtained by hsp65 amplification/sequencing were compared retrospectively and prospectively to those obtained by and the FluoroType®-Mycobacteria VER 1.0 kit. RESULTS: The overall agreement between hsp65 amplification/sequencing and the FluoroType®-Mycobacteria VER 1.0 kit was 88.4% (84/95); 91.2% (52/57) for the retrospective period and 84.2% (32/38) for the prospective period. There were 9 (9.5%) minor discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified at genus level): 4 during the retrospective period, 5 during the prospective period; and 2 (2.1%) major discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified incorrectly to species level): 1 during the retrospective period (M. kumamotonense identified as M. abscessus subsp massiliense by the kit) and 1 during the prospective period (M. chimaera identified as M. smegmatis by the kit). Including concordant results at genus level and minor discrepancies, 17.9% (17/95) of strains were identified as Mycobacterium sp. by the FluoroType®-Mycobacteria-VER 1.0 kit. CONCLUSION: The good performance of the FluoroType®-Mycobacteria-VER 1.0 kit with few major discrepancies could enable its use for first-line identification of positive mycobacteria cultures. However, an alternative identification method at least for reference laboratories is needed owing to the non-negligible proportion of NTM strains were identified at genus level.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nontuberculous MycobacteriaHumansRetrospective StudiesProspective StudiesFranceBacterial ProteinsMycobacteriumPolymerase Chain ReactionMycobacterium Infections, NontuberculousChaperonin 60Molecular Diagnostic TechniquesSensitivity and Specificity

Stichwörter der Autor:innen

Fluorotype®-Mycobacteria VER 1.0IdentificationNontuberculous mycobacteria

Substanzen

Bacterial ProteinsChaperonin 60heat-shock protein 65, Mycobacterium

Autor:innen und Institutionen

  • Laboratoire des Mycobactérie, Laboratoire de biologie médicale multi-site, Groupement Hospitalier Nord, Hospices civils de Lyon, Lyon, France.
  • Laboratoire des Mycobactérie, Laboratoire de biologie médicale multi-site, Groupement Hospitalier Nord, Hospices civils de Lyon, Lyon, France. elisabeth.hodille@chu-lyon.fr.

Zitieren

APA

Piasecki, L., Genestet, C., Benito, Y., Rasigade, J. P., Lina, G., Dumitrescu, O., & Hodille, E. (2024). Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-04825-8

Vancouver

Piasecki L, Genestet C, Benito Y, Rasigade JP, Lina G, Dumitrescu O, et al. Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center. European Journal of Clinical Microbiology & Infectious Diseases. 2024. doi:10.1007/s10096-024-04825-8

BibTeX
@article{Piasecki2024,
  author = {Piasecki, Lisa and Genestet, Charlotte and Benito, Yvonne and Rasigade, Jean-Philippe and Lina, Gérard and Dumitrescu, Oana and Hodille, Elisabeth},
  title = {Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center},
  journal = {European Journal of Clinical Microbiology & Infectious Diseases},
  year = {2024},
  doi = {10.1007/s10096-024-04825-8}
}
Kostenlos starten →